Non-myeloablative allogeneic stem cell transplantation (also known
as mini-transplantation or reduced-intensity conditioning
transplantation) is a major advance in the field of hematopoietic
transplantation within the last 5 years. This approach uses
non-cytotoxic or reduced-intensity cytotoxic therapy to prepare
patients for allografting of hematopoietic stem cells and
lymphocytes. It has the potential to deliver the potent anti-tumor
immunotherapy and bone marrow replacement capacity of allogeneic
stem cell transplantation to patients with reduced
treatment-related morbidity and mortality. It may also enable
allogeneic transplantation in patients who would be considered
ineligible for conventional transplants because of co-morbidity or
advanced age. However, this approach may necessitate more careful
monitoring of post-transplant chimerism and malignant
disease-status than is usual with conventional allografting. There
is also controversy regarding the best preparative regimen and
graft-versus-host disease prophylaxis to use.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!